Integrating Buprenorphine Into HIV Treatment

Status unconfirmed · Phase 4

Conditions studied: Opiate Dependence, HIV Infections

In brief

We hypothesize that integrating drug treatment into HIV treatment will improve HIV outcomes as well as drug treatment outcomes in heroin users. This study will test this hypothesis by randomizing patients to two groups. The first group will receive HIV treatment and buprenorphine treatment contemporaneously at their HIV clinic. The second group will receive HIV treatment at their HIV clinic, and go to another facility to receive buprenorphine treatment services. We will look at HIV outcomes such as CD4 counts, HIV viral loads, and attendance at appointments and drug treatment outcomes such as receipt of buprenorphine and urine toxicology testing.

Key facts

Study ID
NCT00241930
Run by
Organization to Achieve Solutions in Substance Abuse (OASIS)
People needed
60
Starts
2005-09-01
Expected to finish
2009-02-01
Last updated by the study team
2005-10-25

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.